Thomas Trimarchi Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Thomas Trimarchi is President and CFO of BridgeBio Pharma, Inc.. Currently has a direct ownership of 523,305 shares of BBIO, which is worth approximately $17.7 Million. The most recent transaction as insider was on Mar 19, 2025, when has been sold 109,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 523K
22.27% 3M change
n/a 12M change
Total Value Held $17.7 Million

Thomas Trimarchi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2025
BUY
Grant, award, or other acquisition
-
109,100 Added 17.25%
523,305 Common Stock
Feb 16 2025
SELL
Payment of exercise price or tax liability
$480,991 $34.9 p/Share
13,782 Reduced 3.22%
414,205 Common Stock
Dec 10 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 10.46%
427,987 Common Stock
Nov 16 2024
SELL
Payment of exercise price or tax liability
$425,441 $23.72 p/Share
17,936 Reduced 4.53%
377,987 Common Stock
Aug 16 2024
SELL
Payment of exercise price or tax liability
$437,638 $24.4 p/Share
17,936 Reduced 4.33%
395,923 Common Stock
Aug 06 2024
BUY
Grant, award, or other acquisition
-
19,003 Added 4.39%
413,859 Common Stock
TT

Thomas Trimarchi

President and CFO
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO